2615 Efficacy and tolerability of axitinib in metastatic renal cell carcinoma (mRCC): Comparison of Czech clinical registry and AXIS trial data

Authors :: Radek Lakomý
Tomas Buchler
Rostislav Vyzula
Karel Hejduk
Kristina Kubačková
Hana Študentová
Bohuslav Melichar
Ondřej Fiala
Petra Holečková
Alexandr Poprach
Source :: European Journal of Cancer. 51:S516
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Czech
Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.disease
language.human_language
Surgery
Axitinib
Tolerability
Renal cell carcinoma
Internal medicine
language
medicine
Clinical registry
business
medicine.drug

Full Text Access

Tools